Cargando…
A novel CD74-ROS1 gene fusion in a patient with inflammatory breast cancer: a case report
BACKGROUND: CD74-ROS1 fusion genes have been detected in non-small cell lung carcinomas (NSCLC), but not in inflammatory breast cancer. CASE PRESENTATION: Herein, we report a CD74-ROS1 fusion gene identified in a 64-year-old Chinese woman with inflammatory breast cancer (IBC). The patient initially...
Autores principales: | Hu, Huiyu, Ding, Nianhua, Zhou, Haiyan, Wang, Shouman, Tang, Lili, Xiao, Zhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164741/ https://www.ncbi.nlm.nih.gov/pubmed/34051833 http://dx.doi.org/10.1186/s13256-021-02876-5 |
Ejemplares similares
-
A patient with classic biphasic pulmonary blastoma harboring CD74–ROS1 fusion responds to crizotinib
por: Meng, Zhaoting, et al.
Publicado: (2017) -
Complete and durable response to crizotinib in a patient with malignant pleural mesothelioma harboring CD74-ROS1 fusion
por: Xie, Xuehua, et al.
Publicado: (2022) -
Roles of neutrophil/lymphocyte ratio in prognosis and in differentiation of potential beneficiaries in HER2-positive breast cancer with trastuzumab therapy
por: Ding, Nianhua, et al.
Publicado: (2020) -
A Novel ROS1-FBXL17 Fusion Co-Existing with CD74-ROS1 Fusion May Improve Sensitivity to Crizotinib and Prolong Progression-Free Survival of Patients with Lung Adenocarcinoma
por: Lan, Shaowei, et al.
Publicado: (2020) -
Intrinsic resistance to ROS1 inhibition in a patient with
CD74‐ROS1
mediated by AXL overexpression
por: Peters, Tara L., et al.
Publicado: (2023)